4
Changes in Ownership
AEON Biopharma, Inc. Filed Acc 0001104659-23-083567
Options or other derivatives
- Chief Medical Officer acquired 361,167 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Oh Chad · Chief Medical Officer
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-21 | Grant or award : show line 1 in the form Stock Option | +145,588 | 145,588 | D |
| 2023-07-21 | Grant or award : show line 2 in the form Stock Option | +115,151 | 115,151 | D |
| 2023-07-21 | Grant or award : show line 3 in the form Restricted Stock Units | +100,428 | 100,428 | D |
Loading xslF345X05/tm2321918-10_4seq1.xml…